June 8, 2023
June 8, 2023 - Novaliq GmbH announced that the U.S. Food and Drug Administration (FDA) has approved Vevye TM (cyclosporine ophthalmic solution)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
June 1, 2023
Effective on 7/1/2023 As your Prescription Benefit Facilitator, BeneCard PBF is committed to providing the highest quality service, innovative clinical solutions, and valuable trend management strategies
June 1, 2023
Effect on July 1, 2023 BeneCard PBF is committed to providing innovative clinical solutions, valuable trend management strategies, and the highest quality of service. We regularly conduct a review of our
June 1, 2023
Researchers Explore Ozempic as a Potential Addiction Treatment
Following patient testimony on its ability to curb addiction, researchers have begun
Following patient testimony on its ability to curb addiction, researchers have begun
June 1, 2023
Abiomed Recalls Specific Impella 5.5 with SmartAssist for Purge Fluid Leaks that Can Cause Pump Stop
and Loss of Support
Abiomed is recalling specific Impella 5.5 with SmartAssist sets after receiving
Abiomed is recalling specific Impella 5.5 with SmartAssist sets after receiving
June 1, 2023
June 1, 2023 - Coherus BioSciences announced plans to launch Yusimry its Humira biosimilar,
Yusimry (adalimumab-aqvh) is a tumor necrosis factor (TNF) blocker
June 1, 2023
June 1, 2023 - AstraZeneca and Merck, known as MSD outside of the United States and Canada
May 31, 2023
May 31, 2023 - Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has
approved AbrysvoTM (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion